RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-0.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.76B
AUM Growth
+$4.76B
(-5.8%)
Cap. Flow
+$78.2M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
26.26%
Holding
166
New
11
Increased
69
Reduced
16
Closed
13
Top Buys
| 1 |
Baxter International
BAX
|
$36.2M |
| 2 |
Warby Parker
WRBY
|
$34.5M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$30.3M |
| 4 |
Immuneering
IMRX
|
$28.9M |
| 5 |
Ascendis Pharma
ASND
|
$26.5M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$68.6M |
| 2 |
Ardelyx
ARDX
|
$39.8M |
| 3 |
Biogen
BIIB
|
$39.3M |
| 4 |
Boston Scientific
BSX
|
$34.2M |
| 5 |
PPD
PPD, Inc. Common Stock
PPD
|
$31.1M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Consumer Staples | 1.58% |
| 3 | Industrials | 0.82% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Collegium Pharmaceutical
COLL
$1.22B
| $17.8M | 0.37% | 900,000 -20,000 | -2% | -$395K |
|
77
Rigel Pharmaceuticals
RIGL
$697M
| $17.4M | 0.37% | 4,793,400 +38,500 | +0.8% | +$140K |
|
78
Spero Therapeutics
SPRO
$116M
| $17.3M | 0.36% | 941,543 -24,385 | -3% | -$449K |
|
79
Legend Biotech
LEGN
$6.41B
| $15.9M | 0.34% | 315,218 +2,600 | +0.8% | +$131K |
|
|
AMYT
80
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $15.6M | 0.33% | +1,295,225 | New | +$15.6M |
|
81
Kura Oncology
KURA
$686M
| $15.4M | 0.32% | 822,500 +5,700 | +0.7% | +$107K |
|
82
Relay Therapeutics
RLAY
$619M
| $14.8M | 0.31% | 469,560 +19,302 | +4% | +$609K |
|
83
AnaptysBio
ANAB
$569M
| $14.5M | 0.31% | 535,832 +600 | +0.1% | +$16.3K |
|
|
RXDX
84
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $14.5M | 0.3% | 610,136 +14,040 | +2% | +$333K |
|
85
NeueHealth
NEUE
$59.2M
| $14.4M | 0.3% | 1,765,000 -610,000 | -26% | -$4.98M |
|
86
Leap Therapeutics
LPTX
$12M
| $14.1M | 0.3% | +3,508,270 | New | +$14.1M |
|
87
Nkarta
NKTX
$151M
| $14M | 0.29% | 503,148 +5,200 | +1% | +$145K |
|
88
Biomea Fusion
BMEA
$116M
| $14M | 0.29% | 1,165,582 | – | – |
|
89
Aurinia Pharmaceuticals
AUPH
$1.58B
| $13.6M | 0.29% | 613,269 -172,500 | -22% | -$3.82M |
|
90
MacroGenics
MGNX
$112M
| $13.4M | 0.28% | 641,816 +186,000 | +41% | +$3.89M |
|
|
VINC
91
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $12.9M | 0.27% | +800,295 | New | +$12.9M |
|
92
Fulcrum Therapeutics
FULC
$351M
| $12.8M | 0.27% | +455,290 | New | +$12.8M |
|
93
West Pharmaceutical
WST
$17.8B
| $12.7M | 0.27% | 30,000 +1,500 | +5% | +$637K |
|
94
Akero Therapeutics
AKRO
$3.74B
| $12.7M | 0.27% | 568,701 +40,100 | +8% | +$896K |
|
95
Spyre Therapeutics
SYRE
$996M
| $12.5M | 0.26% | 1,577,296 | – | – |
|
|
OLK
96
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $12.2M | 0.26% | 505,000 +80,000 | +19% | +$1.94M |
|
97
Rocket Pharmaceuticals
RCKT
$354M
| $12.1M | 0.25% | 403,270 | – | – |
|
|
MREO
98
Mereo BioPharma
MREO
$272M
| $11.7M | 0.25% | 4,832,978 +290,209 | +6% | +$702K |
|
99
Applied Therapeutics
APLT
$71M
| $11.6M | 0.24% | 701,680 | – | – |
|
100
Prelude Therapeutics
PRLD
$68.5M
| $11.3M | 0.24% | 362,359 -20,000 | -5% | -$625K |
|